teysuno
nordic group b.v. - ftorafūrs, gimeracil, oteracil - kuņģa-zarnu trakta traucējumi - antineoplastiski līdzekļi - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - karcinoma, švamšā šūna - antineoplastiski līdzekļi - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
rehair (2021.) pulveris
pulveris
erivedge
roche registration gmbh - vismodegib - karcinoma, bazālā šūna - antineoplastiski līdzekļi - erivedge ir norādīts ārstēšanai pieaugušiem pacientiem ar:- simptomātiska metastātisku bazālo šūnu karcinomu - lokāli papildu bazālo šūnu karcinomu nepiemērotu operācijas vai radioterapijas.
numient
amneal pharma europe ltd - levodopu, carbidopa - parkinsona slimība - anti-parkinsona zāles - simptomātiska ārstēšana pieaugušiem pacientiem ar parkinsona slimību.
aptamil® nutribiotik™ 1 pulveris
sia ''nutricia'' 40103070928 gustava zemgala gatve 74, rīga, lv-1039, latvija - pulveris - maisījumi zīdaiņiem - piena maisījums zīdaiņiem
epam skvorcova 21 (paziņots 2008.) šķidrums
belinne preparāti epam - šķidrums
epam skvorcova 20 (paziņots 2008.) šķidrums
belinne preparāti epam - šķidrums
aptamil® 1, 2x200 ml šķidrums, gatavs lietošanai, šķidrā veidā
sia ''nutricia'' 40103070928 gustava zemgala gatve 74, rīga, lv-1039, latvija - Šķidrums, gatavs lietošanai, šķidrā veidā - maisījumi zīdaiņiem - piena maisījums zīdaiņiem
aquipta
abbvie deutschland gmbh & co. kg - atogepant - migrēnas traucējumi - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.